A Novel Radiotherapy Approach for Keloids with Intrabeam

Abstract EN

Background.

Keloids are hard nodules or plaques formed by excessive proliferation of connective tissue.

Radiotherapy, widely used in various benign and malignant skin diseases, is an effective treatment for keloids.

This work evaluates Intrabeam photon radiotherapy in the management of keloids.

Methods.

Fourteen patients who have undergone Intrabeam radiotherapy for a total of 15 sites of keloids were followed up.

Twelve cases were first onset and the other two had recurrent diseases.

Thirteen patients underwent surgical resection of keloids before radiotherapy.

One relapsing patient received only 2 rounds of radiation therapy as she could not be reoperated.

Radiotherapy was divided into 2 sessions on days 0 and 3 after surgery.

The dose was 4 or 5 Gy each time for 3 min 14 s to 12 min 1 s.

In addition, we compared our data to the recurrence of keloids in fourteen patients who had previously been exposed to electron beam using conventional accelerators.

Results.

We analyzed the treatment for adverse reactions and recurrence.

In the Intrabeam group, one patient developed superficial skin ulcers a month after treatment.

No one experienced wound rupture, bleeding, infection, skin contractures, or obvious hyperpigmentation.

None of the fourteen cases showed any recurrence so far after on median 22.5 months of follow-up.

Five patients in the electron beam group relapsed 3 to 10 months after treatment.

Conclusion.

Here, Intrabeam photon radiotherapy was shown to be an effective treatment for keloid scars and it is therefore recommended for management of this disease.